Journal article

Clinical care of children and adolescents with COVID-19: recommendations from the National COVID-19 Clinical Evidence Taskforce

David Fraile Navarro, Britta Tendal, David Tingay, Nan Vasilunas, Lorraine Anderson, James Best, Penelope Burns, Saskia Cheyne, Simon S Craig, Simon J Erickson, Nicholas SS Fancourt, Zoy Goff, Vimbai Kapuya, Catherine Keyte, Lorelle Malyon, Steve McDonald, Heath White, Danielle Wurzel, Asha C Bowen, Brendan McMullan

MEDICAL JOURNAL OF AUSTRALIA | WILEY | Published : 2021

Abstract

INTRODUCTION: The epidemiology and clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are different in children and adolescents compared with adults. Although coronavirus disease 2019 (COVID-19) appears to be less common in children, with milder disease overall, severe complications may occur, including paediatric inflammatory multisystem syndrome (PIMS-TS). Recognising the distinct needs of this population, the National COVID-19 Clinical Evidence Taskforce formed a Paediatric and Adolescent Care Panel to provide living guidelines for Australian clinicians to manage children and adolescents with COVID-19 and COVID-19 complications. Living guidel..

View full abstract

Grants

Awarded by National Health and Medical Research Council Clinical Research Fellowship


Funding Acknowledgements

The National COVID-19 Clinical Evidence Taskforce acknowledges the member organisations, partners, governments and funders that support the initiative (online Supporting Information). These guidelines have received funding from the Australian Government Department of Health, the Victorian Government Department of Health and Human Services, the Ian Potter Foundation, the Walter Cottman Endowment Fund managed by Equity Trustees, the Lord Mayor's Charitable Foundation, and the Victorian Government Operational Infrastructure Support Program. David Tingay was supported by a National Health and Medical Research Council Clinical Research Fellowship (Grant ID 1053889).